51 reports of this reaction
2.8% of all BAYER GENUINE ASPIRIN reports
#4 most reported adverse reaction
MYOCARDIAL INFARCTION is the #4 most commonly reported adverse reaction for BAYER GENUINE ASPIRIN, manufactured by Bayer HealthCare LLC.. There are 51 FDA adverse event reports linking BAYER GENUINE ASPIRIN to MYOCARDIAL INFARCTION. This represents approximately 2.8% of all 1,811 adverse event reports for this drug.
Patients taking BAYER GENUINE ASPIRIN who experience myocardial infarction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MYOCARDIAL INFARCTION is a less commonly reported adverse event for BAYER GENUINE ASPIRIN, but still significant enough to appear in the safety profile.
In addition to myocardial infarction, the following adverse reactions have been reported for BAYER GENUINE ASPIRIN:
The following drugs have also been linked to myocardial infarction in FDA adverse event reports:
MYOCARDIAL INFARCTION has been reported as an adverse event in 51 FDA reports for BAYER GENUINE ASPIRIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
MYOCARDIAL INFARCTION accounts for approximately 2.8% of all adverse event reports for BAYER GENUINE ASPIRIN, making it a notable side effect.
If you experience myocardial infarction while taking BAYER GENUINE ASPIRIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.